Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring MET Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models-Reference-Cited by-同舟云学术

Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring MET Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models

Published:2017-08-01 Issue:21 Volume:23 Page:6661-6672
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Engstrom Lars D.,Aranda Ruth,Lee Matthew,Tovar Elizabeth A.,Essenburg Curt J.,Madaj Zachary,Chiang Harrah,Briere David,Hallin Jill,Lopez-Casas Pedro P.,Baños Natalia,Menendez Camino,Hidalgo Manuel,Tassell Vanessa,Chao Richard,Chudova Darya I.,Lanman Richard B.,Olson Peter,Bazhenova Lyudmilla,Patel Sandip Pravin,Graveel Carrie,Nishino Mizuki,Shapiro Geoffrey I.,Peled Nir,Awad Mark M.,Jänne Pasi A.,Christensen James G.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents;Bioorganic Chemistry;2024-10

2. Capmatinib efficacy for METex14 non-small cell lung cancer patients: Results of the IFCT-2104 CAPMATU study;Lung Cancer;2024-10

3. Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy;Journal of Medicinal Chemistry;2024-08-01

4. Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus Trametinib in Patients With Metastatic Nonsmall Cell Lung Center Harboring MET Exon 14 Skipping Mutations and Other MET-Alterations;Clinical Lung Cancer;2024-07

5. Discovery of Dual MER/AXL Kinase Inhibitors as Bifunctional Small Molecules for Inhibiting Tumor Growth and Enhancing Tumor Immune Microenvironment;Journal of Medicinal Chemistry;2024-06-24